Will supply 10 cr Covishield doses in June: Serum Institute to Centre

Will supply 10 cr Covishield doses in June: Serum Institute to Centre

Will supply 10 cr Covishield doses in June: Serum Institute to Centre

Serum Institute of India (SII) has informed the government that it will manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaints by states about the shortage of anti-coronavirus vaccine jabs.

serum institute of india vaccine

 

 

In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock despite various challenges because of the pandemic.

 

 

“We are pleased to inform that in June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country as compared to our production capacity of 6.5 crore doses in May,” Prakash Kumar Singh, the Director of Government and Regulatory Affairs at SII, said in the letter.

 

 

Singh also thanked Shah for his “valuable guidance and continuous support” at various stages of their endeavour to make India ‘aatmanirbhar’ (self-sufficient) in COVID-19 vaccines and making them available for the people of the country.

 

 

Also Read: Why interval between two doses of vaccines is stretched?

 

 

“Serum Institute of India has always been sincerely concerned about the protection of the citizens of our country and world at large from COVID-19. Under the leadership of our CEO, Adar C Poonawalla, our team have been working relentlessly shoulder to shoulder with our government to fight the COVID-19 pandemic,” he said in the letter.

 

 

“We assure you that with the support of the Government of India and under your kind guidance, we are trying our best by utilizing all of our resources to increase our production capacity of Covishield in the coming month also.”

 

 

In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crores in June, seven crore in July and 10 crores each in August and September.

 

 

India is currently using made-in-India vaccines — Covishield manufactured by SII and Covaxin of Bharat Biotech — in its COVID-19 immunisation programme.

 

 

The Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for emergency use and is being used in a few private hospitals.

arun singh

I am Arun Singh, a student of BSc non medical who loves to do graphic designing in free time. I love to read books about investing,self improvement and biographies of successful people. I want to become a millionaire before the age of 30 and do something big for the world that I can be proud of after 30 years from now.

Leave a Reply